SE8903003D0 - Novel medical use - Google Patents
Novel medical useInfo
- Publication number
- SE8903003D0 SE8903003D0 SE8903003A SE8903003A SE8903003D0 SE 8903003 D0 SE8903003 D0 SE 8903003D0 SE 8903003 A SE8903003 A SE 8903003A SE 8903003 A SE8903003 A SE 8903003A SE 8903003 D0 SE8903003 D0 SE 8903003D0
- Authority
- SE
- Sweden
- Prior art keywords
- medical use
- novel medical
- thioredoxin
- interferons
- immunoglobulins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
- C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
- C12Y108/01008—Protein-disulfide reductase (1.8.1.8), i.e. thioredoxin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8903003A SE8903003D0 (sv) | 1989-09-12 | 1989-09-12 | Novel medical use |
IL95583A IL95583A0 (en) | 1989-09-12 | 1990-09-04 | Pharmaceutical compositions comprising thioredoxin |
IE323390A IE903233A1 (en) | 1989-09-12 | 1990-09-06 | Novel medical use |
HU92821A HUT62932A (en) | 1989-09-12 | 1990-09-10 | Process for producing pharmaceutical compositions comprising thioredoxin |
CA002065454A CA2065454A1 (en) | 1989-09-12 | 1990-09-10 | Use of thioredoxin in the treatment of malignantly transformed cells in animals and man |
AU64336/90A AU641942B2 (en) | 1989-09-12 | 1990-09-10 | The use of thioredoxin in the treatment of malignantly transformed cells in animals and man |
GR900100679A GR1001151B (el) | 1989-09-12 | 1990-09-10 | Νεα xρηση θειορεδοξινης |
PCT/SE1990/000578 WO1991004320A1 (en) | 1989-09-12 | 1990-09-10 | The use of thioredoxin in the treatment of malignantly transformed cells in animals and man |
EP90913906A EP0489113A1 (en) | 1989-09-12 | 1990-09-10 | The use of thioredoxin in the treatment of malignantly transformed cells in animals and man |
DD90343919A DD298056A5 (de) | 1989-09-12 | 1990-09-10 | Arzneimittel |
JP2512956A JPH05500216A (ja) | 1989-09-12 | 1990-09-10 | 新規な医療用途 |
PT95284A PT95284A (pt) | 1989-09-12 | 1990-09-11 | Novo metodo de tratamento de doencas malignas com tioredoxina |
NO920911A NO920911D0 (no) | 1989-09-12 | 1992-03-06 | Anvendelse av tioredoksin for behandling av maligne transformerte celler i dyr og mennesker |
FI921058A FI921058A0 (fi) | 1989-09-12 | 1992-03-11 | Anvaendning av thioredoxin vid behandling av elakartade transformade celler i djur och maenniska. |
BG096034A BG96034A (bg) | 1989-09-12 | 1992-03-11 | Приложение на тиоредоксин за лечението на злокачествено трансформирани клетки при животни и хора |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8903003A SE8903003D0 (sv) | 1989-09-12 | 1989-09-12 | Novel medical use |
Publications (1)
Publication Number | Publication Date |
---|---|
SE8903003D0 true SE8903003D0 (sv) | 1989-09-12 |
Family
ID=20376862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8903003A SE8903003D0 (sv) | 1989-09-12 | 1989-09-12 | Novel medical use |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0489113A1 (sv) |
JP (1) | JPH05500216A (sv) |
AU (1) | AU641942B2 (sv) |
CA (1) | CA2065454A1 (sv) |
DD (1) | DD298056A5 (sv) |
FI (1) | FI921058A0 (sv) |
GR (1) | GR1001151B (sv) |
HU (1) | HUT62932A (sv) |
IE (1) | IE903233A1 (sv) |
PT (1) | PT95284A (sv) |
SE (1) | SE8903003D0 (sv) |
WO (1) | WO1991004320A1 (sv) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7744877B2 (en) | 1992-11-13 | 2010-06-29 | Biogen Idec Inc. | Expression and use of anti-CD20 Antibodies |
DE69329503T2 (de) | 1992-11-13 | 2001-05-03 | Idec Pharma Corp | Therapeutische Verwendung von chimerischen und markierten Antikörpern, die gegen ein Differenzierung-Antigen gerichtet sind, dessen Expression auf menschliche B Lymphozyt beschränkt ist, für die Behandlung von B-Zell-Lymphoma |
AU3643497A (en) * | 1996-06-28 | 1998-01-21 | National Jewish Center For Immunology And Respiratory Medicine | Use of thioredoxin-like molecules for induction of mnsod to treat oxidative damage |
WO1998024472A1 (en) * | 1996-12-06 | 1998-06-11 | Garth Powis | Uses of thioredoxin |
US6689775B2 (en) | 1999-06-03 | 2004-02-10 | Arizona Board Of Regents, Acting On Behalf Of The University Of Arizona | Uses of thioredoxin |
US5919657A (en) * | 1997-04-09 | 1999-07-06 | Incyte Pharmaceuticals, Inc. | Nucleic acids encoding human thioredoxin protein; related reagents |
US7585645B2 (en) | 1997-05-27 | 2009-09-08 | Sembiosys Genetics Inc. | Thioredoxin and thioredoxin reductase containing oil body based products |
US6566514B1 (en) | 1998-01-30 | 2003-05-20 | Genesense Technologies Inc. | Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth |
ATE414536T1 (de) | 1998-08-11 | 2008-12-15 | Biogen Idec Inc | Kombinationstherapien gegen b-zell-lymphome beinhaltend die verabreichung von anti-cd20- antikörpern |
EP1949910A1 (en) | 1998-11-09 | 2008-07-30 | Biogen Idec, Inc. | Treatment of chronic lymphocytic leukemia (CLL) using chimeric anti-CD20 antibody. |
US8557244B1 (en) | 1999-08-11 | 2013-10-15 | Biogen Idec Inc. | Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody |
WO2002016600A2 (en) * | 2000-08-25 | 2002-02-28 | Curagen Corporation | Novel proteins and nucleic acids encoding same |
CA2498581C (en) | 2002-09-10 | 2019-03-19 | National Jewish Medical And Research Center | Thioredoxin composition and uses thereof for liquefaction of mucus or sputum |
MX2015013040A (es) | 2013-03-15 | 2016-05-24 | Orpro Therapeutics Inc | Producto y proceso para normalización de la viscosidad del moco. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2633295B2 (ja) * | 1987-06-12 | 1997-07-23 | 味の素株式会社 | ヒトadfをコードする遺伝子 |
-
1989
- 1989-09-12 SE SE8903003A patent/SE8903003D0/sv unknown
-
1990
- 1990-09-06 IE IE323390A patent/IE903233A1/en unknown
- 1990-09-10 HU HU92821A patent/HUT62932A/hu unknown
- 1990-09-10 JP JP2512956A patent/JPH05500216A/ja active Pending
- 1990-09-10 GR GR900100679A patent/GR1001151B/el unknown
- 1990-09-10 WO PCT/SE1990/000578 patent/WO1991004320A1/en not_active Application Discontinuation
- 1990-09-10 DD DD90343919A patent/DD298056A5/de not_active IP Right Cessation
- 1990-09-10 AU AU64336/90A patent/AU641942B2/en not_active Ceased
- 1990-09-10 EP EP90913906A patent/EP0489113A1/en not_active Withdrawn
- 1990-09-10 CA CA002065454A patent/CA2065454A1/en not_active Abandoned
- 1990-09-11 PT PT95284A patent/PT95284A/pt not_active Application Discontinuation
-
1992
- 1992-03-11 FI FI921058A patent/FI921058A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUT62932A (en) | 1993-06-28 |
CA2065454A1 (en) | 1991-03-13 |
PT95284A (pt) | 1991-08-14 |
JPH05500216A (ja) | 1993-01-21 |
DD298056A5 (de) | 1992-02-06 |
WO1991004320A1 (en) | 1991-04-04 |
GR900100679A (en) | 1992-01-20 |
AU6433690A (en) | 1991-04-18 |
IE903233A1 (en) | 1991-03-27 |
FI921058A0 (fi) | 1992-03-11 |
AU641942B2 (en) | 1993-10-07 |
GR1001151B (el) | 1993-05-24 |
EP0489113A1 (en) | 1992-06-10 |
HU9200821D0 (en) | 1992-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8903003D0 (sv) | Novel medical use | |
CA2075060A1 (en) | Novel vehicle gases and their use in medical preparations | |
DK0396404T3 (da) | Farmaceutisk middel indeholdende loratadin, ibuprofen og pseudoephedrin | |
DE3889350D1 (de) | Kautschukzusammensetzung und ihre Verwendung bei der Herstellung von Packungen und Schläuchen. | |
NL8601053A (nl) | Imidazochinolinen met antithrombogene en cardiotonische eigenschappen. | |
DE69017874D1 (de) | EPROM-Anordnung mit metallenen Source-Anschlüssen und ihre Herstellung. | |
DE3850246D1 (de) | Metall und komposit des metalls mit kautschuk. | |
NO871053L (no) | Anvendelse av substituerte n-triklormetyltiodikarboksimider i kombinasjon med n,n[-substituerte bis-(2,4-diamino-s-triazin-6-yl)-oligosulfider i vulkaniserbare kautsjukblandinger og slike kautsjukblandinger. | |
DE69230798D1 (de) | Rekombinante immuntoxine | |
IT8621222A0 (it) | Procedimento di (co)polimerizzazione di alfa-olefine in presenza di antiossidanti. | |
NZ230155A (en) | N-2,3-butadienyl-n"-substituted-triamindalkanes and alkenes, and pharmaceutical compositions | |
ATE58639T1 (de) | Appetit mildernde und gegen gastritis wirksame zusammensetzung. | |
NO894008L (no) | Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme. | |
FR2355505A1 (fr) | Nouvel agent adjuvant immunitaire | |
DE3881099D1 (de) | Acrylkautschuk, zusammensetzung aus acrylkautschuk und gegenstaende aus vernetztem acrylkautschuk. | |
ES2061566T3 (es) | Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo. | |
ZA849576B (en) | 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases | |
ATE45675T1 (de) | Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen. | |
IL84040A (en) | Monoclonal antibodies against ifn-omega,their preparation and their use in the purification and detection of ifn-omega | |
AU561309B2 (en) | Diarylindane-1,3-diones | |
EP0301373A3 (en) | Products containing gallopamil and prazosine | |
DE3767175D1 (de) | Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen. | |
ATE132500T1 (de) | 24r-scymnol, herstellung und verwendung | |
ATE89569T1 (de) | Haemoglobin mit reduziertem virusrisiko und dessen herstellung. | |
FI885025A0 (fi) | Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning. |